Understanding the Synthesis and Applications of 6-Iodo-4(H)-quinazolinone
In the intricate world of pharmaceutical manufacturing, chemical intermediates act as the essential LEGO bricks that build complex life-saving drugs. One such crucial component is 6-Iodo-4(H)-quinazolinone, a compound whose precise synthesis and high purity are fundamental to the creation of advanced therapeutics, most notably in the field of oncology. NINGBO INNO PHARMCHEM CO.,LTD., a reputable supplier from China, specializes in providing this vital quinazolinone derivative to the global pharmaceutical research community.
The compound, chemically known as 6-Iodo-4(H)-quinazolinone (CAS: 16064-08-7), is characterized by its distinctive brown powder appearance and a high melting point, indicating its stable chemical nature. Its primary application lies in its role as a key intermediate for Lapatinib, a targeted therapy drug used in the treatment of certain types of cancer. The pharmaceutical industry’s reliance on such intermediates necessitates a focus on reliable R&D supply chains. Companies often look for manufacturers who can guarantee consistent quality and timely delivery, impacting the overall price and accessibility of the final drug.
The synthesis of 6-Iodo-4(H)-quinazolinone involves sophisticated organic chemistry techniques to ensure a high degree of purity, a critical factor for its use in pharmaceutical research. As a building block for active pharmaceutical ingredients (APIs), its specifications must meet rigorous standards. Pharmaceutical companies and research institutions depend on these intermediates to streamline their drug development processes, ensuring that their R&D pipelines are robust and efficient. Understanding the chemical significance of such quinazoline derivatives provides insight into their broad impact on pharmaceutical innovation.
For those involved in advanced organic chemistry, 6-Iodo-4(H)-quinazolinone represents a valuable material for complex synthesis projects. Its precise chemical structure allows for specific reactions and modifications, paving the way for the discovery of new therapeutic agents. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting this innovation by offering a product that adheres to stringent quality control standards. The continuous pursuit of improved synthesis routes and manufacturing excellence ensures that this critical intermediate remains available to drive progress in medicine.
The compound, chemically known as 6-Iodo-4(H)-quinazolinone (CAS: 16064-08-7), is characterized by its distinctive brown powder appearance and a high melting point, indicating its stable chemical nature. Its primary application lies in its role as a key intermediate for Lapatinib, a targeted therapy drug used in the treatment of certain types of cancer. The pharmaceutical industry’s reliance on such intermediates necessitates a focus on reliable R&D supply chains. Companies often look for manufacturers who can guarantee consistent quality and timely delivery, impacting the overall price and accessibility of the final drug.
The synthesis of 6-Iodo-4(H)-quinazolinone involves sophisticated organic chemistry techniques to ensure a high degree of purity, a critical factor for its use in pharmaceutical research. As a building block for active pharmaceutical ingredients (APIs), its specifications must meet rigorous standards. Pharmaceutical companies and research institutions depend on these intermediates to streamline their drug development processes, ensuring that their R&D pipelines are robust and efficient. Understanding the chemical significance of such quinazoline derivatives provides insight into their broad impact on pharmaceutical innovation.
For those involved in advanced organic chemistry, 6-Iodo-4(H)-quinazolinone represents a valuable material for complex synthesis projects. Its precise chemical structure allows for specific reactions and modifications, paving the way for the discovery of new therapeutic agents. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting this innovation by offering a product that adheres to stringent quality control standards. The continuous pursuit of improved synthesis routes and manufacturing excellence ensures that this critical intermediate remains available to drive progress in medicine.
Perspectives & Insights
Quantum Pioneer 24
“Pharmaceutical companies and research institutions depend on these intermediates to streamline their drug development processes, ensuring that their R&D pipelines are robust and efficient.”
Bio Explorer X
“Understanding the chemical significance of such quinazoline derivatives provides insight into their broad impact on pharmaceutical innovation.”
Nano Catalyst AI
“For those involved in advanced organic chemistry, 6-Iodo-4(H)-quinazolinone represents a valuable material for complex synthesis projects.”